Abbott to Acquire Exact Sciences for $21 Billion

Abbott to Acquire Exact Sciences for $21 Billion

On November 20, Abbott and Exact Sciences announced a definitive agreement for Abbott to acquire Exact Sciences. The deal will enable Abbott to enter and lead in cancer diagnostics segments, serving millions more people. Under the terms of the agreement, Exact Sciences shareholders will receive $105 per common share, representing a total equity value of approximately $21 billion and an estimated enterprise value of $23 billion. Abbott’s financing contemplates absorption of Exact Sciences’ estimated $1.8 billion of net debt. As a leading provider of cancer screening and diagnostics tests, Exact Sciences helps patients and healthcare providers make timely, informed decisions... Read More »
RadNet Announces Three Acquisitions in November  

RadNet Announces Three Acquisitions in November  

Since the start of November, RadNet, Inc. has announced three acquisitions: River Radiology, CIMAR UK and Alpha RT assets. With these acquisitions, RadNet has announced 11 transactions throughout the year.   River Radiology is a radiology practice based in Kingston, New York. It provides digital radiology, ultrasound, MRI and CT scan services. The number of physicians on staff was not disclosed. Steve Forthuber, COO of RadNet, said RadNet plans to merge the imaging center with its Lenox Hill Radiology network of centers across downstate New York.   CIMAR UK is a provider of cloud-native healthcare image management solutions. CIMAR’s infrastructure supports data... Read More »
Align Capital Partners-Backed Premier Biotech Acquires National Test Systems 

Align Capital Partners-Backed Premier Biotech Acquires National Test Systems 

On November 5, Premier Biotech announced that it acquired National Test Systems (NTS) for an undisclosed price.  NTS is a leading provider of rapid point-of-care diagnostic drug screening supplies and services throughout the United States. NTS serves more than 1,500 facilities and is based in Boca Raton, Florida.  Premier Biotech delivers rapid and innovative diagnostic solutions that promote health, safety and compliance. The company is a leading provider of proprietary oral fluid (OralTox® and OT-Scan®) and other products, services and technology solutions designed to simplify and provide a seamless end-to-end experience for customers. Premier Biotech’s integrated offering is... Read More »
Fibronostics Acquires Stone Clinical Laboratories

Fibronostics Acquires Stone Clinical Laboratories

Fibronostics has announced the completion of its acquisition of Stone Clinical Laboratories, LLC, based in New Orleans, Louisiana. The transaction was finalized on October 27, 2025. Stone Clinical Laboratories is a leading provider of advanced laboratory services in the United States. The company specializes in preventative and molecular diagnostics testing supported by a customer-focused boutique service. Fibronostics is a global health technology company specializing in non-invasive diagnostic solutions for chronic diseases, with a focus on liver and metabolic disorders. Its flagship platform, LIVERFASt®, enables clinicians to assess liver health quickly and at scale. The company... Read More »
Abbott to Acquire Exact Sciences for $21 Billion

Versant Diagnostics Expands into Georgia With SouthEastern Pathology Deal

Versant Diagnostics has announced a strategic partnership with SouthEastern Pathology. SouthEastern Pathology is a College of American Pathologists-accredited provider based in Rome, Georgia. The company’s board-certified pathologists and staff have been providing personalized pathology services for physicians and patients throughout the Southeastern United States for more than 50 years. Founded in 2021 by Ven Aduana, M.D., Jim Billington and Brian Carr, Versant Diagnostics is an independent physician services company focused on anatomic pathology. Versant Diagnostics provides services for hospitals and physician practices. Versant Diagnostics is focused on rapidly advancing digital... Read More »
GE HealthCare to Acquire Brain Imaging Company Icometrix

GE HealthCare to Acquire Brain Imaging Company Icometrix

GE HealthCare announced on September 10 that it entered into an agreement to acquire AI-powered imaging analysis company Icometrix. Founded in 2011, Icometrix is a healthcare technology company developing imaging analysis technology for neurological disorders such as Alzheimer’s disease. GE Healthcare, a subsidiary of General Electric (GE), is an American multinational medical technology company headquartered in Chicago, Illinois. It was spun-off from GE on January 4, 2023, with GE retaining 13.5% ownership. GE HealthCare provides digital infrastructure, data analytics and decision support tools designed to help in the diagnosis, treatment and monitoring of patients. The deal remains... Read More »